CAMLINFINE

CAMLIN FINE SCIENCES

Small Cap BSE: 532834 NSE: CAMLINFINE
₹156.75
-0.9 (-0.57%)
As on 04 December, 2022 | 21:45

Camlin Fine Sciences Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in CAMLIN FINE SCIENCES

Start SIP

Camlin Fine Sciences Share Price

Camlin Fine Sciences Share Returns

  • Over 1 Month 1.52%
  • Over 3 Month 20.62%
  • Over 6 Month 32.17%
  • Over 1 Year 12.45%

Camlin Fine Sciences Key Statistics

P/E Ratio 39.2
PEG Ratio 1.1
Market Cap Cr 2,462
Price to Book Ratio 3.6
EPS 1.6
Dividend 0
Relative Strength Index 54.41
Money Flow Index 57.24
MACD Signal 5.62
Average True Range 6.5

Camlin Fine Sciences Investment Rating

  • Master Rating:
  • Camlin Fine Sciences has an operating revenue of Rs. 1,637.06 Cr. on a trailing 12-month basis. An annual revenue growth of 21% is outstanding, Pre-tax margin of 7% is okay, ROE of 9% is fair but needs improvement. The company has a debt to equity of 59%, which is bit higher. The stock from a technical standpoint is comfortably placed above its key moving averages, around 11% and 22% from 50DMA and 200DMA. It has recently broken out of a base in its weekly chart and is trading around 11% from the pivot point (which is extended from the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 89 which is a GOOD score indicating consistency in earnings, a RS Rating of 67 which is FAIR indicating the recent price performance, Buyer Demand at A+ which is evident from recent demand for the stock, Group Rank of 102 indicates it belongs to a poor industry group of Chemicals-Specialty and a Master Score of B is close to being the best. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Camlin Fine Sciences Financials
IndicatorSep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021
Oper Rev Qtr Cr 243155201200138146168
Operating Expenses Qtr Cr 201140170177135127149
Operating Profit Qtr Cr 4215312331920
Depreciation Qtr Cr 7777767
Interest Qtr Cr 161610671010
Tax Qtr Cr 12065-324
Net Profit Qtr Cr 1951612-752

Camlin Fine Sciences Technicals

EMA & SMA

Current Price
156.75
-0.9 (-0.57%)
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 0
  • 20 Day
  • 156
  • 50 Day
  • 146
  • 100 Day
  • 137.47
  • 200 Day
  • 134.85
  • 20 Day
  • 157.23
  • 50 Day
  • 141.09
  • 100 Day
  • 131.43
  • 200 Day
  • 128.12

Camlin Fine Sciences Resistance and Support

PIVOT
₹158.87
Resistance
First Resistance 160.49
Second Resistance 163.32
Third Resistance 164.94
RSI 54.41
MFI 57.24
MACD Single Line 5.62
MACD 4.62
Support
First Resistance 156.04
Second Resistance 154.42
Third Resistance 151.59

Camlin Fine Sciences Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 394,434 17,899,415 45.38
Week 625,499 25,889,395 41.39
1 Month 649,252 29,846,121 45.97
6 Month 443,150 20,265,262 45.73

Camlin Fine Sciences Result Highlights

Camlin Fine Sciences Synopsis

NSE-Chemicals-Specialty

Camlin Fine Sciences belongs to the Industry of Chemicals - Others. Company’s Total Operating Revenue is Rs. 685.51 Cr. and Equity Capital is Rs. 15.70 Cr. for the Year ended 31/03/2022. Camlin Fine Sciences Ltd. is a Public Limited Listed company incorporated on 30/11/1993 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L74100MH1993PLC075361 and registration number is 075361.
Market Cap 2,462
Sales 800
Shares in Float 12.88
No of funds 46
Yield 0.47
Book Value 4.18
U/D Vol ratio 1.4
LTDebt / Equity 44
Alpha 0.05
Beta 1.11

Camlin Fine Sciences

Owner NameSep-22Jun-22Mar-22Dec-21
Promoters 17.55%17.56%17.56%
Mutual Funds 12.86%13.51%13.71%
Foreign Portfolio Investors 11.32%10.74%10.5%
Financial Institutions/ Banks
Individual Investors 30.37%30.85%30.4%
Others 27.9%27.34%27.83%

Camlin Fine Sciences Management

Name Designation
Mr. Ashish Dandekar Chairman & Managing Director
Mr. Nirmal Momaya Managing Director
Mr. Arjun Dukane Executive Director
Ms. Anagha Dandekar Non Exe.Non Ind.Director
Mr. Harsha Raghavan Non Exe.Non Ind.Director
Mr. Sarvjit Bedi Non Exe.Non Ind.Director
Mr. Amol Shah Independent Director
Mr. Sutapa Banerjee Independent Director
Mr. Conrad D?souza Independent Director
Mr. Mahabaleshwar Palekar Independent Director
Mr. Thomas Videbaek Independent Director
Mr. Pradip Kanakia Independent Director

Camlin Fine Sciences Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Camlin Fine Sciences Corporate Action

Date Purpose Remarks
2022-11-12 Quarterly Results
2022-08-12 Quarterly Results
2022-05-19 Audited Results
2022-02-07 Quarterly Results
2021-11-12 Quarterly Results

Camlin Fine Sciences MF Shareholding

Name Amount(cr)
SBI Flexicap Fund Regular Growth 16495
ICICI Prudential Smallcap Fund Growth 4388
ICICI Prudential Focused Equity Fund Growth 3866
ICICI Prudential MidCap Fund Growth 3661
ICICI Prudential Dividend Yield Equity Fund Growth 1181

Camlin Fine Sciences FAQs

What is Share Price of Camlin Fine Sciences ?

Camlin Fine Sciences share price is ₹156 As on 04 December, 2022 | 21:31

What is the Market Cap of Camlin Fine Sciences ?

The Market Cap of Camlin Fine Sciences is ₹2462 Cr As on 04 December, 2022 | 21:31

What is the P/E ratio of Camlin Fine Sciences ?

The P/E ratio of Camlin Fine Sciences is 39.2 As on 04 December, 2022 | 21:31

What is the PB ratio of Camlin Fine Sciences ?

The PB ratio of Camlin Fine Sciences is 3.6 As on 04 December, 2022 | 21:31

Q2FY23